Positron emission tomography evaluation of sedative properties of antihistamines
- PMID: 21521134
- DOI: 10.1517/14740338.2011.562889
Positron emission tomography evaluation of sedative properties of antihistamines
Abstract
Introduction: H(1) antihistamines are often used in the medication for allergic diseases, coughs and colds, and insomnia, with or without prescription, even though their sedative properties are a potentially dangerous unwanted side effect that is not properly recognized. These sedative properties have been evaluated using the incidence of subjective sleepiness, objective cognitive and psychomotor functions, and positron emission tomography (PET) measurement of H(1) receptor occupancy.
Areas covered: This article reviews the current updated literature on the sedative properties of antihistamines examined by PET measurement of H(1) receptor occupancy.
Expert opinion: The use of PET to examine antihistamine penetration in the human brain in relation to psychometric and other functional measures of CNS effects is a major breakthrough and provides a new standard by which the functional CNS effects of antihistamines can be related directly to H(1) receptor occupancy. Therapy with antihistamines can be better guided by considering histamine H(1) receptor occupancy from the view of their sedative properties.
Similar articles
-
Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.J Clin Pharmacol. 2004 Aug;44(8):890-900. doi: 10.1177/0091270004267590. J Clin Pharmacol. 2004. PMID: 15286093 Clinical Trial.
-
[A potential of positron emission tomography in the drug development of non-sedative antihistamines].Nihon Yakurigaku Zasshi. 2003 Nov;122 Suppl:78P-80P. Nihon Yakurigaku Zasshi. 2003. PMID: 14727529 Japanese.
-
Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin.Br J Clin Pharmacol. 2008 Jun;65(6):811-21. doi: 10.1111/j.1365-2125.2008.03143.x. Epub 2008 Apr 11. Br J Clin Pharmacol. 2008. PMID: 18410464 Free PMC article. Clinical Trial.
-
The clinical pharmacology of non-sedating antihistamines.Pharmacol Ther. 2017 Oct;178:148-156. doi: 10.1016/j.pharmthera.2017.04.004. Epub 2017 Apr 27. Pharmacol Ther. 2017. PMID: 28457804 Review.
-
[Molecular imaging of histamine receptors in the human brain].Brain Nerve. 2007 Mar;59(3):221-31. Brain Nerve. 2007. PMID: 17370648 Review. Japanese.
Cited by
-
Pathobiology of Second-Generation Antihistamines Related to Sleep in Urticaria Patients.Biology (Basel). 2022 Mar 11;11(3):433. doi: 10.3390/biology11030433. Biology (Basel). 2022. PMID: 35336805 Free PMC article.
-
Economic Burden of the Inadequate Management of Allergic Rhinitis and Urticaria in Asian Countries Based on the GA²LEN Model.Allergy Asthma Immunol Res. 2018 Jul;10(4):370-378. doi: 10.4168/aair.2018.10.4.370. Allergy Asthma Immunol Res. 2018. PMID: 29949833 Free PMC article.
-
Chemical Probes for Histamine Receptor Subtypes.Curr Top Behav Neurosci. 2022;59:29-76. doi: 10.1007/7854_2021_254. Curr Top Behav Neurosci. 2022. PMID: 34595743
-
Central nervous system effects of the second-generation antihistamines marketed in Japan--review of inter-drug differences using the proportional impairment ratio (PIR)-.PLoS One. 2014 Dec 12;9(12):e114336. doi: 10.1371/journal.pone.0114336. eCollection 2014. PLoS One. 2014. PMID: 25501360 Free PMC article. Review.
-
Efficacy and Safety of Non-brain Penetrating H1-Antihistamines for the Treatment of Allergic Diseases.Curr Top Behav Neurosci. 2022;59:193-214. doi: 10.1007/7854_2021_265. Curr Top Behav Neurosci. 2022. PMID: 34622396 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical